Prognostic factors that increase the risk for reduced white matter volumes and deficits in attention and learning for survivors of childhood cancers

Pediatric Blood and Cancer

Volumn 61, Issue 6, 2014, Pages 1074-1079

  Reddick, Wilburn E ^a   Taghipour, Delaram J ^a   Glass, John O ^a   Ashford, Jason ^a   Xiong, Xiaoping ^a   Wu, Shengjie ^a   Bonner, Melanie ^b   Khan, Raja B ^a   Conklin, Heather M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer survivors; Childhood ALL; Computer assisted image analysis; Magnetic resonance imaging; Malignant primary brain tumors; Neuropsychology

Indexed keywords

METHYLPHENIDATE;

ACADEMIC ACHIEVEMENT; ACUTE LYMPHOBLASTIC LEUKEMIA; AGE DISTRIBUTION; ARTICLE; ATTENTION; ATTENTION DISTURBANCE; BASAL GANGLION; BRAIN SIZE; BRAIN TUMOR; CANCER PROGNOSIS; CANCER SURVIVOR; CEREBROSPINAL FLUID; CHILDHOOD LEUKEMIA; COGNITION; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GRAY MATTER; HUMAN; INTELLECT; INTELLIGENCE; INTELLIGENCE QUOTIENT; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REACTION TIME; SEX DIFFERENCE; SIBLING; TREATMENT DURATION; WHITE MATTER;

CANCER SURVIVORS; CHILDHOOD ALL; COMPUTER-ASSISTED IMAGE ANALYSIS; MAGNETIC RESONANCE IMAGING; MALIGNANT PRIMARY BRAIN TUMORS; NEUROPSYCHOLOGY;

AGE FACTORS; ANTINEOPLASTIC AGENTS; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; BRAIN DAMAGE, CHRONIC; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CRANIAL IRRADIATION; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, SPINAL; INTELLIGENCE; LEARNING DISORDERS; LEUKOENCEPHALOPATHIES; MAGNETIC RESONANCE IMAGING; MALE; METHYLPHENIDATE; NEUROPSYCHOLOGICAL TESTS; ORGAN SIZE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; PROSPECTIVE STUDIES; RADIATION INJURIES; RISK; SURVIVORS;

EID: 84901721302     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24947     Document Type: Article

References (44)

1. Pui C-H, Sandlund JT, Pei D, et al. Improved outcome for children with acute lymphoblastic leukemia: Results of total therapy study XIIIB at St Jude Children's Research Hopital. Blood 2004; 104:2690-2696.
2. Pui C-H, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 2009; 360:2730-2741.
3. CBTRUS. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2008. 2012.
4. Packer RJ, Gajjar A, Vezina G, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 2006; 24:4202-4208.
5. Gajjar A, Chintagumpala M, Ashley D, et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): Long-term results from a prospective, multicentre trial. Lancet Oncol 2006; 7:813-820.
6. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006; 355:1572-1582.
7. Pui C-H, Pei D, Sandlund JT, et al. Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 2005; 23:7936-7941.
8. Spiegler BJ, Kennedy K, Maze R, et al. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. J Clin Oncol 2006; 24:3858-3864.
9. Campbell LK, Scaduto M, Sharp W, et al. A meta-analysis of the neurocognitve sequelae of treatment for childhood acute lymphocytic leukemia. Pediatr Blood Cancer 2007; 49:65-73.
10. Mulhern RK, Merchant TE, Gajjar A, et al. Late neurocognitive sequelae in survivors of brain tumors in childhood. Lancet 2004; 5:399-408.
11. Buizer AI, De Sonneville LMJ, van den Heuvel-Eibrink MM, et al. Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: Effect of treatment intensity. Pediatr Blood Cancer 2005; 45:281-290.
12. Mulhern RK, Palmer SL, Merchant TE, et al. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol 2005; 23:5511-5519.
13. Mabbott DJ, Penkman L, Witol A, et al. Core neurocognitive functions in children treated for posterior fossa tumors. Neuropsychology 2008; 22:159-168.
14. Jain N, Krull KR, Brouwers P, et al. Neuropsychological outcome following intensity-modulated radiation therapy for pediatric medulloblastoma. Pediatr Blood Cancer 2008; 51:275-279.
15. Reeves CB, Palmer SL, Reddick WE, et al. Attention and memory functioning among pediatric patients with medulloblastoma. J Pediatr Psychol 2006; 31:272-280.
16. Ashford J, Schoffstall C, Reddick WE, et al. Attention and working memory abilities in children treated for acute lymphoblastic leukemia. Cancer 2010; 116:4638-4645.
17. Mabbott DJ, Monsalves E, Spiegler BJ, et al. Longitudinal evaluation of neurocognitive function after treatment for central nervous system germ cell tumors in childhood. Cancer 2011; 117:5402-5411.
18. Mulhern RK, Butler RW. Neurocognitive sequelae of childhood cancers and their treatment. Pediatr Rehabil 2004; 7:1-14.
19. Filley CM, Kleinschmidt-DeMasters BK. Toxic leukoencephalopathy. N Engl J Med 2001; 345:425-432.
20. Mulhern RK, Reddick WE, Palmer SL, et al. Neurocognitive deficits in medulloblastoma survivors and white matter loss. Ann Neurol 1999; 46:834-841.
21. Reddick WE, Russell JM, Glass JO, et al. Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced-dose cranial-spinal irradiation. Magn Reson Imaging 2000; 18:787-793.
22. Mulhern RK, Palmer SL, Reddick WE, et al. Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. J Clin Oncol 2001; 19:472-479.
23. Reddick WE, Glass JO, Palmer SL, et al. Atypical white matter volume development in children following craniospinal irradiation. Neuro Oncol 2005; 7:12-19.
24. Reddick WE, Glass JO, Helton KJ, et al. Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate. AJNR Am J Neuroradiol 2005; 26:1263-1269.
25. Reddick WE, Glass JO, Helton KJ, et al. A quantitative MRI assessment of leukoencephalopathy in children treated for acute lymphoblastic leukemia without irradiation. AJNR Am J Neuroradiol 2005; 26:2371-2377.
26. Paakko E, Harila-Saari A, Vanionpaa L, et al. White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: Correlation with neuropsychological findings. Med Pediatr Oncol 2000; 35:456-461.
27. Chu WCW, Chik KW, Chan YL, et al. White matter and cerebral metabolite changes in children undergoing treatment for acute lymphoblastic leukemia: Longitudinal study with MR imaging and 1H MR spectroscopy. Radiology 2003; 229:659-669.
28. Mulhern RK, Khan RB, Kaplan S, et al. Short-term efficacy of methylphenidate: A randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. J Clin Oncol 2004; 22:4795-4803.
29. The Psychological Corporation. Wechsler Intelligence Test for Children -III. New York, NY: Harcourt, Brace Jovanovich, Inc.; 1992.
30. The Psychological Corporation. The Wechsler Adult Intelligence Scale-III. New York, NY: Harcourt, Brace Jovanovich, Inc.; 1997.
31. Sattler JM. Table L-13 in assessment of children. San Diego, CA: Publisher. Inc.; 1992. p. 1172.
32. Conners CK. The Conner's Continuous Performance Test. Toronto, Canada: Multi-Health Systems; 1995.
33. The Psychological Corporation. The Wechsler Individual Achievement Test. New York, NY: Harcourt, Brace Jovanovich, Inc.; 1992.
34. Blatter DD, Bigler ED, Gale SD, et al. Quantitative volumetric analysis of brain MR: Normative database spanning 5 decades of life. AJNR Am J Neuroradiol 1995; 16:241-251.
35. Matsumae M, Kikinis R, Morocz I, et al. Age-related changes in intracranial compartment volumes in normal adults assessed by magnetic resonance imaging. J Neurosurg 1996; 84:982-991.
36. Glass JO, Ji Q, Glas LS, et al. Prediction of total cerebral tissue volumes in normal appearing brain from subsampled segmentation volumes. Magn Reson Imaging 2003; 21:977-982.
37. Ji Q, Glass JO, Reddick WE. A novel, fast entropy-minimization algorithm for bias field correction in MR images. Magn Reson Imaging 2007; 25:259-264.
38. Reddick WE, Glass JO, Cook EN, et al. Automated segmentation and classification of multispectral magnetic resonance images of brain using artifical neural networks. IEEE Trans Med Imaging 1997; 16:911-918.
39. Connor JR, Menzies SL. Relationship of iron to oligodendrocytes and myelination. Glia 1996; 17:83-93.
40. Vymazal J, Brooks RA, Baumgarner C. The relation between brain iron and NMR relaxation times: An in vitro study. Magn Reson Med 1996; 35:56-61.
41. Smith B. Brain damage after intrathecal methotrexate. J Neurol Neurosurg Psychiatry 1975; 38:810-815.
42. Mabbott DJ, Noseworthy M, Bouffet E, et al. Diffusion tensor imaging of white matter after cranial radiation in children for medulloblastoma: Correlation with IQ. Neuro Oncol 2006; 8:244-252.
43. Aukema EJ, Caan MWA, Oudhuis N, et al. White matter fractional anisotropy correlates with speed of processing and motor speed in young childhood cancer survivors. Int J Radiat Oncol Biol Phys 2009; 74:837-843.
44. Palmer SL, Glass JO, Li Y, et al. White matter integrity is associated with cognitive processing in patients treated for a posterior fossa brain tumor. Neuro Oncol 2012; 14:1185-1193.